Nov 12 (Reuters) - Catabasis Pharmaceuticals Inc :
* CATABASIS PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
* Q3 LOSS PER SHARE $0.56
* Q3 EARNINGS PER SHARE ESTIMATE $-0.51 -- REFINITIV IBES DATA
* CASH AND CASH EQUIVALENTS TOTALED $52.9 MILLION AS OF SEPTEMBER 30, 2020
* EXPECTS THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS FOR AT LEAST NEXT 12 MONTHS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。